These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34457069)
1. Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation. Luo M; Zhou Y Oncol Lett; 2021 Oct; 22(4):714. PubMed ID: 34457069 [TBL] [Abstract][Full Text] [Related]
2. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications. Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Wu M; Li X; Huang W; Chen Y; Wang B; Liu X Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946 [TBL] [Abstract][Full Text] [Related]
4. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells. Gong YQ; Peng D; Ning XH; Yang XY; Li XS; Zhou LQ; Guo YL Oncol Lett; 2016 Dec; 12(6):4485-4492. PubMed ID: 28101210 [TBL] [Abstract][Full Text] [Related]
5. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151 [TBL] [Abstract][Full Text] [Related]
6. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis. Yu C; Chen F; Jiang J; Zhang H; Zhou M Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250 [TBL] [Abstract][Full Text] [Related]
7. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis. Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105 [TBL] [Abstract][Full Text] [Related]
8. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis Guo J; Wang M; Wang JP; Wu CX World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276 [TBL] [Abstract][Full Text] [Related]
10. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136 [TBL] [Abstract][Full Text] [Related]
11. UBE2T is a prognostic biomarker and correlated with Th2 cell infiltrates in retinoblastoma. Wang Z; Chen N; Liu C; Cao G; Ji Y; Yang W; Jiang Q Biochem Biophys Res Commun; 2022 Jul; 614():138-144. PubMed ID: 35594577 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel ubiquitination-related gene Qu G; Xu Y; Qu Y; Qiu J; Chen G; Zhao N; Deng J Front Oncol; 2023; 13():1000949. PubMed ID: 36910645 [TBL] [Abstract][Full Text] [Related]
13. Identification of crucial genes and pathways associated with colorectal cancer by bioinformatics analysis. Liu X; Liu X; Qiao T; Chen W Oncol Lett; 2020 Mar; 19(3):1881-1889. PubMed ID: 32194683 [TBL] [Abstract][Full Text] [Related]
14. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer. Zhu X; Li T; Niu X; Chen L; Ge C Oncol Lett; 2020 Oct; 20(4):44. PubMed ID: 32802166 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression. Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591 [TBL] [Abstract][Full Text] [Related]
16. Increased Expression of Zou R; Xu H; Li F; Wang S; Zhu L DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631 [TBL] [Abstract][Full Text] [Related]
17. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis. Li J; Wang Y; Wang X; Yang Q World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis. Chen J; Wang Z; Shen X; Cui X; Guo Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508 [TBL] [Abstract][Full Text] [Related]
19. Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer. Zhang X; Zhang X; Shen L; Song L; Wu J; Cao G; Chen X; Zhu B Exp Ther Med; 2019 Dec; 18(6):4481-4489. PubMed ID: 31772638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]